Center for Rare Neurological Diseases
				
				
					5600 Oakbrook Parkway					
Norcross, Georgia 30093
														
          Norcross, Georgia 30093
We've found
        7 trials
        at this facility
      	
	Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder Clinical Trial
	
Updated: 12/31/1969
  
  
  A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Spinal Muscular Atrophy Clinical Trial
	
Updated: 12/31/1969
  
  
  Pre-Symptomatic Study of Intravenous AVXS-101 in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Epilepsy Clinical Trial
	
Updated: 12/31/1969
  
  
  Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Rett Syndrome Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate Ketamine for the Treatment of Rett Syndrome
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Neurology, Other Clinical Trial
	
Updated: 12/31/1969
  
  
  A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Patients With Developmental and/or Epileptic Encephalopathies
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	 Clinical Trial
	
Updated: 12/31/1969
  
  
  A Multicenter, Open-label, Pilot Study of TAK-935 (OV935) in Participants With 15Q Duplication Syndrome or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Rett Syndrome Clinical Trial
	
Updated: 2/5/2018
  
  
  Treatment of Mitochondrial Dysfunction in Rett Syndrome With Triheptanoin
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 2/5/2018
Click here to add this to my saved trials
	    
	